IMAC Holdings (NASDAQ:BACK) reported $3.78 million in sales this quarter.
Immunovant: Q1 Earnings Insights
Immunovant (NASDAQ:IMVT) reported its Q1 earnings results on Friday, August 5, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Immunovant beat estimated earnings by 12.5%, reporting an EPS of $-0.35 versus an estimate of $-0.4.